Based on the forecasted data for stomach malignant neoplasms mortality among females in Canada, it is projected that the number of deaths will slightly decrease from 2024 to 2028, starting at 736 deaths in 2024 and reducing to 733 deaths by 2028. In 2023, the actual figure was slightly above the forecasted 2024 value, indicating a consistent annual decline. With minimal yearly variation evident in the data, the compound annual growth rate (CAGR) reflects a modest decrement trend.
Future trends to watch for include potential influences of advancements in medical treatments, early detection methods, and lifestyle changes that could further reduce mortality rates in the long term.